Objective: Osteolytic lesions of the skull in children have a broad differential diagnosis including congenital, inflammatory and neoplastic lesions. Progressive osteolysis of the skull secondary to head trauma is rare and has been poorly characterized. Methods: The pediatric database at our hospital was screened for children with osteolytic lesions who had a previous mild head injury without fracture or dural tears. We identified 2 children with circumscribed progressive cranial osteolysis after minor head trauma detected by CT and MRI scans. Three additional cases were found in a review of the published literature. Results: Ten children with an osteolytic skull lesion treated between January 1998 and February 2008 were identified in our pediatric database. In 2 children there was evidence of previous mild head injury without a skull fracture. Trauma had occurred 7 and 2 months prior to presentation, respectively. The inner table of the skull was intact in both cases. In 1 case, surgery was performed, and in the other case, a wait-and-see strategy was adopted. Pathological examination in case 1 revealed an organized hemorrhage with focal papillary endothelial hyperplasia. Conclusions: Progressive osteolytic calvarial lesions may occur in both infants and adolescents after mild head injury. They involve either only the diploe and outer table of the skull or both the inner and outer tables. These lesions might be due to intradiploic or subgaleal hematomas triggering an inflammatory process. While surgical resection can be considered to confirm a histopathological diagnosis and to exclude other diagnoses, spontaneous reossification is possible.

Keywords:
Progressive osteolytic skull lesion, Minor head trauma, Reossification
1.
Gugliantini P, Caione P, Fariello G, Rivosecchi M: Post traumatic leptomeningeal cyst in infancy. Pediatr Radiol 1980;9:11–14.
2.
Mahapatra AK, Tandon PN: Post traumatic intradiploic pseudomeningocele in children. Acta Neurochir (Wien) 1989;100:120–126.
3.
Hornig GW, Beatty RM: Osteolytic skull lesions secondary to trauma. Report of two cases. J Neurosurg 1990;72:506–508.
4.
Hecimovic I, Dmitrovic B, Rubin O, Rukovanjski M, Vrankovic D: Skull osteolysis after mild head trauma: case report. Surg Neurol 1999;51:43–46.
5.
Gibson SE, Prayson RA: Primary skull lesions in the pediatric population. A 25-year experience. Arch Pathol Lab Med 2007;131:761–766.
6.
Stark AM, Eichmann T, Mehdorn HM: Skull metastases: clinical features, differential diagnosis and review of the literature. Surg Neurol 2003;60:219–226.
7.
Wecht DA, Sawaya R: Lesions of the calvaria: surgical experience with 42 patients. Ann Surg Oncol 1997;4:28–36.
8.
Smirniotopoulos JG, Chiechi MV: Teratomas, dermoids, and epidermoids of the head and neck. Radiographics 1995;15:1437–1455.
9.
Link MP, Eilber F: Osteosarcoma; in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, Lippincott, 1989, pp 689–711.
10.
Miser JS, Triche TJ, Pritchard DJ, Kinsella TJ: Ewing’s sarcoma and non-rhabdomyosarcoma soft tissue sarcomas of childhood; in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, Lippincott, 1989, pp 659–688.
11.
Crowe L, Babl F, Anderson V, Catroppa C: The epidemiology of pediatric head injuries: data from a referral centre in Victoria, Australia. J Paediatr Child Health 2009;45:346–350.
12.
Novak JA, Ferguson DJ, Komorowski RA: Fine needle aspiration cytology of papillary endothelial hyperplasia. A case report. Acta Cytol 1999;43:663–666.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.